baber/WOPTO huggingface dataset:
Patent WO-2008057054-A1 (WO)
Title: Dna complexing agents
Inventor: YU HSIAO-HUA
IPC: C07D519/00
Filed: 2007-11-09
Abstract: The invention provides a compound of structure (I): wherein X is S, O or NRN, where RN is H or alkyl; L is a linker group; Q is a group capable of binding with dsDNA; G and G' are, independently, absent or have between 1 and 20 main chain atoms; FG is a functional moiety comprising at least one O or N atom or a transition metal complex; and R is selected from the group consisting of H, alkyl, alkoxy or OCRaRb coupled to an atom in L so as to form a six-membered ring. Ra and Rb are independently H or optionally substituted alkyl.
Patent SG-141372-A1 (SG)
Title: Conductivity improving combination of cerium oxide and detergents for diesel fuels
Inventor: ROOS JOSEPH W
Filed: 2007-09-19
Abstract: CONDUCTIVITY IMPROVING COMBINATION OF CERIUM OXIDE AND DETERGENTS FOR DIESEL FUELS The disclosure provides conductivity improving concentrates and methods for improving conductivity and reducing risks associated with static discharge in middle distillate fuel composition compositions, particularly diesel fuels. The conductivity improvement is provided with the combination of cerium oxide nanoparticles and dispersant/detergent and shows aged conductivity comparable to or higher than that obtained with conventional antistatic agents. NO DRAWING
Patent SG-137850-A1 (SG)
Title: Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
Inventor: SNOW ALAN D
IPC: C07C235/56
Filed: 2005-05-12
Abstract: Substituted n-aryl benzamides, related compounds and their pharmaceutically acceptable derivatives, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, including A(3 amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment are provided.
Patent SG-144911-A1 (SG)
Title: High density plasma and bias rf power process to make stable fsg with less free f and sin with less h to enhance the fsg/sin integration reliability
Inventor: WEI LU
Filed: 2005-11-07
Abstract: HIGH DENSITY PLASMA AND BIAS RF POWER PROCESS TO MAKE STABLE FSG WITH LESS FREE F AND SIN WITH LESS H TO ENHANCE THE FSG/SIN INTEGRATION RELIABILITY An embodiment of the invention is a HDP CVD FSG layer and an HDP CVD SIN layer with more stability (e.g., less free F and less free H). A feature is that the FSG and SIN are formed using a HDP CVD process with a high plasma density between 1E12 and 1E15 ions/cc and more preferably between 1E14 and 1E15 ions/cc. The high bias has sufficient energy to break the F-Si bonds in the FSG. The high bias has sufficient energy to break the H-Si bonds in the silicon nitride. Whereby the FSG layer has less F and the SiN layer has less H that increases the FSG/SiN interface reliability. The embodiments can be used on smooth surfaces (non-gap fill applications).
Patent SG-149060-A1 (SG)
Title: Method and apparatus for recording and/or reproducing data on/from write-once disc, and write-once disc therefor
Inventor: HWANG SUNG-HEE
IPC: G11B7/24
Filed: 2004-12-21
Abstract: METHOD AND APPARATUS FOR RECORDING AND/OR REPRODUCING DATA ON/FROM WRITE- ONCE DISC, AND WRITE-ONCE DISC THEREFOR An apparatus recording and/or reproducing data on/from a write-once disc therefor, the write-once disc having at least one recording layer including: a plurality of temporary defect management areas in which temporary defect list (TDFL) and temporary disc defect structure (TDDS) are recorded, the temporary defect list comprising information on defect areas, and the temporary disc defect structure comprising a location pointer indicating a location in which the temporary defect list is recorded; and at least one access information area in which access information is recorded, the access information indicating a temporary defect management area in which latest temporary defect list and temporary disc defect structure are recorded, among the plurality of temporary defect management areas; wherein the access information is updated in the access information area when the temporary defect management area in which the latest temporary defect list and temporary disc defect structure are recorded, is changed.
Patent SG-158822-A1 (SG)
Title: Full wafer width scanning using step and scan system
Inventor: SEWELL HARRY
Filed: 2009-07-17
Abstract: A system and method are provided for writing a pattern onto a substrate. A patterned beam of radiation is produced using a reticle and projected onto a substrate to expose the pattern. The respective scanning speeds of the reticle and the substrate are controlled to allow the pattern to be exposed across an entire width of the substrate in the scanning direction, while providing a substantial increase in wafer throughput.
Patent SG-157419-A1 (SG)
Title: Apparatus and method for in-mold degating
Inventor: YAP ONG SEE
Filed: 2007-05-28
Abstract: An apparatus and method for degating is provided for separating excess molding material from encapsulated electronic packages while the electronic packages are located in a molding system. At least one holding device is coupled to a mold of the molding system, which is located such that excess molding material is molded onto at least a portion of the holding device during molding. A locking feature on the portion of the holding device locks the excess molding material such that the holding device may hold the excess molding material molded onto it to forcibly separate the excess molding material from the encapsulated electronic packages after molding.
Patent WO-2011081604-A1 (WO)
Title: A method and system for distributing media content over a wireless network
Inventor: SIM WONG HOO
IPC: H04N7/24
Filed: 2010-12-17
Abstract: There is provided a method and system for distributing media content over a wireless network. There may be at least one primary stream of media content and the at least one secondary stream of media content being transmitted either simultaneously or with a time lag. Preferably, the at least one primary stream of media content takes up a substantially higher bandwidth over the wireless network compared to the at least one secondary stream of media content, and the at least one primary stream of media content is dropped by a signal receiver at areas of the wireless network with a degraded signal of the at least one primary stream of media content, where the degraded signal may be in a form which is not readable.
Patent SG-166106-A1 (SG)
Title: Pde inhibitors and combinations thereof for the treatment of urological disorders
Inventor: ULBRICH ERNST
Filed: 2006-09-16
Abstract: The invention provides pharmacological compositions comprising PDE-5 and PDE- 4 inhibitors, alone or in combination, for the treatment of urological disorders comprising Benign Prostate Hyperplasia (BPH), Lower Urinary Tract Symptoms (LUTS) and in particular irritative symptoms caused by BPH-induced bladder outlet obstruction (BOO). The invention also provides methods of screening for such PDE-5 and PDE-4 inhibitors for use, alone and in combination, in the preparation of medicaments for the treatment of said urological disorders. Figure: None
Patent SG-171540-A1 (SG)
Title: Traveling vehicle system and method of non-contact power feeding to traveling vehicle
Inventor: KUZUYA MOTOHIKO
IPC: B65G1/04
Filed: 2010-11-11
Abstract: TRAVELING VEHICLE SYSTEM AND METHOD OF NON-CONTACT POWER FEEDING TO IRAVELING VEHICLE A power supply and a non-contact power feeder cable are provided on the ground.A traveling vehicle is provided with a power receiving unit configured to receive electrical energy from the non-contact power feeder cable, a load consuming electrical energy, and an energy storage unit configured to store electrical energy from the power receiving unit, and supplying electrical energy to the load. Further, control means is provided for keeping track of an amount of electrical energy stored in the energy storage unit and an amount of electrical energy required for the load by control means, and stopping supply of electrical energy to the non-contact power feeder cable by the control means when the electrical energy required for the load can be supplied by the electrical energy stored in the energy storage unit.
Patent SG-173994-A1 (SG)
Title: 3d shutter glasses for use with lcd displays
Inventor: MACNAUGHTON BOYD
IPC: G02B30/25
Filed: 2011-03-04
Abstract: 3D SHUTTER GLASSES FOR USE WITH LCD DISPLAYS A viewing system for viewing video displays having the appearance of a threedimensional image.Fig. 1
Patent SG-170811-A1 (SG)
Title: Process for producing wax ester from dihydroxy fatty acid
Inventor: AWANG ROILA
IPC: C07C51/367
Filed: 2004-08-21
Abstract: A process for producing wax ester comprising of esterifying dihydroxy fatty acid preferably dihydroxystearic acid with at least one alcohol in the presence of lipase as a catalyst which is then remove by filtration. The filtered catalyst could be reuse and provides a number of cost advantages. In the preferred embodiment of the present invention, the dihvdroxystearic acid is derived from palm based oleic acid and the alcohol contains 8 to 18 carbon atoms per molecules.
Patent SG-170822-A1 (SG)
Title: Exchanges for creating and trading derivative securities
Inventor: JOHNSON JOHNNIE ERIC VICTOR
IPC: G06Q40/00
Filed: 2008-03-20
Abstract: A computer system (1) constitutes a primary exchange for creating and trading derivative securities that secure a claim of a nominal derivative security value e.g. $1 or ?1 that is contingent on movement of a numerical variable such as a stock price. The system comprises: (a) a database (4- 14) for storing data defining purchase offers and offers of sale, (b) inputs for receiving offers from traders (16), (c) a decision unit for determining whether or not a match exists between a purchase offer and an offer of sale in the database in terms of the bid and offer prices, the maturity time, stock price at the maturity time, and type of derivative security etc, (d) a derivative security creation module that creates complementary derivative securities, one for each trader, so that only one derivative security will pay out, and (e) a maturity settlement module for paying appropriate traders at the maturity time out of funds received from both traders at commencement of the trade. Derivative securities created by the system may also be traded on the system in a secondary exchange.
Patent SG-171625-A1 (SG)
Title: Antiseptic-containing silicone elastomers
Inventor: LOHRMANN MARC
Filed: 2007-04-17
Abstract: The invention relates to compositions comprising silicone elastomers and antiseptics in homogeneous distribution, to a process for the preparation thereof and to the use thereof in medical articles.
Patent SG-174879-A1 (SG)
Title: Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
Inventor: RENZ MARTIN
Filed: 2010-04-30
Abstract: This invention relates to novel compounds of the Formula Ik, Im1, Im2, Im5, In1, In2, In5, lo1, lo2, lo5, Ip1, Ip3, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell.
Patent SG-174562-A1 (SG)
Title: Hierarchically-organized control galleries
Inventor: ZHAO JASON XIAOBO
IPC: G06F40/00
Filed: 2010-05-10
Abstract: A computing system provides a graphical user interface having hierarchically-organized control galleries. The computing system displays the graphical user interface on a display device. The graphical user interface contains a document area and a control ribbon. The document area contains at least a portion of a document that a user is editing. The control ribbon includes a class control gallery. The class control gallery includes a plurality of class controls associated with different classes of related commands. The computing system displays a variation control gallery containing variation controls in a class associated with a selected one of the class controls. In response to a selection of a variation control in the variation control gallery, the computing system applies a command associated with the variation control to a document in the document area.
Patent SG-177497-A1 (SG)
Title: Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
Inventor: LABRIE FERNAND
Filed: 2010-06-16
Abstract: Novel methods for reduction or elimination of the incidence of hot flushes, vasomotor symptoms, and night sweats while decreasing the risk of acquiring breast, uterine or endometrial cancer and furthermore having beneficial effect by inhibiting the development of osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, hypertension, insulin resistance, diabetes type 2, loss of muscle mass, adiposity, Alzheimer's disease, loss of cognition, loss of memory, or vaginal dryness in susceptible warm-blooded animals including humans involving administration of an amount of a sex steroid precursor, particularly dehydroepiandrosterone (DHEA) and an antiestrogen or a selective estrogen receptor modulator, particularly benzopyran compounds. Pharmaceutical compositions for delivery of active ingredient(s) and kit(s) useful to the invention are also disclosed.
Patent SG-178330-A1 (SG)
Title: Process for making thermoplastic polymer pellets
Inventor: TSOU ANDY H
IPC: B29C48/05
Filed: 2010-08-12
Abstract: Provided is a process for making thermoplastic polymer pellets. The process has the following steps: (a) melting a thermoplastic polymer to form a polymer melt; (b) extruding the melt through a die to form a substantially continuous molten polymer extrudate wherein the die has a contact surface bearing a polymer coating having a surface energy of less than 25 mN/m at 20°C; (c) cooling the extrudate to form a cooled extrudate; and (d) pelletizing the cooled extrudate to form a plurality of polymer pellets. Provided is also a polymer pellet shipping system and a stable thermoplastic polymer pellet.
Patent SG-183663-A1 (SG)
Title: Compositions and methods for the treatment of infections and tumors
Inventor: AHMED RAFI
IPC: A61K39/00
Filed: 2007-12-26
Abstract: COMPOSITIONS AND METHODS FOR THE TREATMENT OF 5 INFECTIONS AND TUMORSPD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an 10 antigen from the infectious agent or tumor. Thus, subjects with infections, such aspersistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjectscan be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically 15 effective amount of a PD-1 antagonist.No suitable figure
Patent SG-183998-A1 (SG)
Title: Systems and processes for treatment of solutions
Inventor: XIA JIYANG
Filed: 2010-07-02
Abstract: A treatment system is provided and comprises a precipitation unit and a recovery unit. The precipitation unit is configured to treat a solution using one or more miscibie organic solvents to produce a mixture of precipitate solids and a liquid. The recov ery unit is in fluid communication with the precipitation unit and configured to facilitate separating the liquid at least into an organic phase liquid and an aqueous phase liquid comprising a portion of the one or more miscible organic solvents. The treatment system further comprises a purification unit comprising one or more membrane devices in fluid communication with the recovery unit and configured to separate at least a portion of the one or more miscible organic solvents in the aqueous phase liquid from the aqueous phase liquid. A treatment system and a treatment process are also presented.
Patent SG-185411-A1 (SG)
Title: Modulators of fatty acid amide hydrolase
Inventor: KEITH JOHN M
Filed: 2011-05-02
Abstract: 4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1 -carboxylic acid (4-chloro-pyridin-3-yl)-amide is described, which is useful as a FAAH modulator. 4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1 -carboxylic acid (4-chloro-pyridin-3-yl)-amide may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). A method of synthesizing 4- (2,2-difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1 -carboxylic acid (4- chloro-pyridin-3-yl)-amide is also disclosed.
Patent WO-2014046618-A1 (WO)
Title: Flexible master - slave robotic endoscopy system
Inventor: PHEE SOO JAY LOUIS
IPC: B25J18/06
Filed: 2013-09-19
Abstract: A master - slave robotic endoscopy system includes a flexible primary endoscope probe having at least one tool channel for carrying a tendon-sheath driven robot arm and corresponding end effector, and a secondary endoscope probe channel for carrying an imaging endoscope. The imaging endoscope provides enhanced image capture range relative to a distal end of the primary endoscope probe by way of a secondary endoscope probe channel distal opening proximally offset from the primary endoscope probe distal end; a ramp structure disially carried by the primary endoscope probe; and/or one or more actuatable distal imaging endoscope regions. Robot arms can include joint primitives that enable robot arm / end effector manipulation in accordance with intended degrees of freedom. A set of quick connect / disconnect interfaces couple an actuation controller to one or more actuation assemblies insertable into the tool channel(s), where each actuation assembly includes tendon-sheath elements, a robot arm, and its corresponding end effector.
Patent SG-187179-A1 (SG)
Title: Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
Inventor: CHATTERJI ASHISH
Filed: 2011-08-08
Abstract: Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a p H-independent in vitro release profile with NMT 70 % in one hour, NMT 85 % in 4 hour, and NLT 80 % in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment- Resistant Depression (TRD) and Fragile X Syndrome.
Patent SG-189740-A1 (SG)
Title: Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
Inventor: BERKENBUSCH THILO
Filed: 2009-09-14
Abstract: 5This invention relates to novel crystalline forms of the following Compound (1), and the sodium salt thereof and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection.10(No suitable figure) -40 37 -
Patent SG-190262-A1 (SG)
Title: Oligosaccharide mixture and food product comprising this mixture, especially infant formula
Inventor: SPRENGER NORBERT
IPC: A23L33/00
Filed: 2011-11-21
Abstract: The invention discloses an oligosaccharide mixture comprising 5-70 wt% of at least one N-acetylated oligosaccharide, 5-90 wt% of at least one neutral oligosaccharide, 2-50 wt% of at least one sialylated oligosaccharide, and/or 5-70 wt% of at least one fucosylated oligosaccharide. The invention also discloses a food product, especially an infant formula, comprising said oligosaccharide mixture.
Patent SG-190357-A1 (SG)
Title: Novel conjugates for targeted drug delivery
Inventor: CHAUDHARY MANU
Filed: 2011-11-21
Abstract: The present invention relates to a novel drug delivery system comprising a drug(s)-protein- polymer triple conjugate. The triple conjugate employes a (i) protein moiety capable of binding selectively to a particular target site possessed by a cell/affected organ, (ii) a polymer moiety, covalently linked to the protein and (iii) an active drug moiety that includes one or more drug(s) covalently linked to either said polymer moiety or to a protein moiety. The conjugates of the present invention have target specificity and better selectivity to a defined population of cells/organs(s). The present invention further relates to methods of preparation and methods of treatment comprising administering said conjugate as a single unit. The conjugates of the present invention are usefully employed in therapeutic as well as non-therapeutic, e.g., diagnostic applications.
Patent SG-195196-A1 (SG)
Title: Dual targeting
Inventor: BECKMANN ROLAND
Filed: 2012-05-29
Abstract: The present invention relates to antibody-based dual targeting molecules, and to methods for generating such dual targeting molecules, including a library-based approach.
Patent WO-2018084806-A1 (WO)
Title: COMPOSITIONS DE ZINC-γ-PGA ET PROCÉDÉS DE TRAITEMENT DU CANCER
Inventor: CHUNG JINHYUK FRED
IPC: A61P35/00
Filed: 2017-10-31
Abstract: La présente invention concerne des compositions pharmaceutiques comprenant un sel de zinc 2+  et un support d'acide γ-polyglutamique, et, facultativement, un inhibiteur de NF-kB en tant qu'agent de sensibilisation de tumeur, et des procédés d'utilisation de telles compositions pour traiter des tumeurs chez des patients. Les procédés comprennent l'administration d'une forme posologique liquide ou d'une forme pharmaceutique solide d'une quantité thérapeutiquement efficace d'un sel de Zn(ll) et d'un support d'acide γ-polyglutamique à un patient en ayant besoin. L'invention concerne en outre des procédés de traitement d'un large spectre de tumeurs humaines, comprenant des tumeurs présentant un phénotype pharmacorésistant, au moyen des compositions de l'invention. Les tumeurs qui répondent aux compositions pharmaceutiques de l'invention comprennent des tumeurs neuroendocrines (neuroblastome), gastriques, utérines et pulmonaires.
Patent WO-2005046652-A1 (WO)
Title: Formulation de ketoprofene a liberation controlee
Inventor: JAKLIC MIHA TOMAZ
IPC: A61K9/50
Filed: 2004-11-11
Abstract: L'invention concerne un nouvelle forme de dosage pharmaceutique multi-unité à libération contrôlée comprenant des comprimés enrobés qui renferment une âme extrudée composée de kétoprofène et d'une cellulose microcristalline, ainsi qu'un enrobage contenant au moins un polymère acido-résistant et au moins un polymère insoluble. Cette formulation convient pour une administration quotidienne de kétoprofène.